{
    "nctId": "NCT04765124",
    "briefTitle": "The Efficacy and Safety of Neoadjuvant Trastuzumab Plus Taxane With and Without Pertuzumab Therapy",
    "officialTitle": "A Multicenter Chart Review Study for Evaluating The Efficacy and Safety of Neoadjuvant Trastuzumab Plus Taxane With and Without Pertuzumab Therapy in Locally Advanced HER2 Positive Breast Cancer Patients",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 1500,
    "primaryOutcomeMeasure": "To evaluate Pathologic Complete Response (pCR) rate",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female patients aged 18 years old and over\n* Patients diagnosed as histologically confirmed (IHC score of 3+ and/or positive by ISH) locally advanced HER2-positive breast cancer with breast surgery.\n* Patients who received as neoadjuvant therapy.\n\nExclusion Criteria:\n\n* Patients transferred from an other hospital should not be included, however, patients' data transferred to an other hospital will be collected till transfer time",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}